The innovation for dry eyes
Since 2015, EvoTears® eye drops have represented an unprecedented therapeutic class in the treatment of dry eyes. The first water-free drops in the treatment of dry eyes specifically address a compromised lipid layer. The latter is the sole underlying cause in almost 60 % of dry eye patients1, leading to an early evaporation of the tear film and thus to dry eyes.
In addition, EvoTears® are the first eye drops with the innovative ingredient perfluorohexyloctane. Thanks to perfluorohexyloctane, EvoTears® eye drops spread quickly and cover the tear like a protective layer. This prevents excessive evaporation and effectively relieves the discomfort of dry eyes.
Due to being water-free, EvoTears® does not need any additives. Tear substitutes are used as a basic therapy for dry eyes, whereby eye drops that apply moisture only have no direct influence on an existing compromised lipid layer. With EvoTears®, an unprecedented therapeutic class in the treatment of dry eyes caused by a compromised lipid layer has been available since 2015.
EvoTears®, the unique2 lipid replacement, convinces with its effectiveness and tolerability and is suitable for most dry eyes patients.








Typical symptoms of a compromised lipid layer are
- Watery eyes
- Burning sensation
- Pronounced complaints in the morning that improve during the day
Causes of a compromised lipid layer are, for example
- Use of digital media
- Draught or air conditioning
- Office Eye Syndrome
- Unfavourable climatic influences/conditions
Digital media3 and dry eyes
What happens when you use digital media3?
Looking concentratedly
- Reduced blinking frequency
- Reduced lipid secretion into the tear film
- compromised lipid layer, thus premature evaporation of the tear
- Dehydration of the ocular surface
- Dry eyes due to digital eye strain
How can EvoTears® help?
- takes over the function of the lipid layer
- counteracts premature evaporation
- prevents dry eyes caused by using digital media3
EvoTears® benefits from
1. Perfluorohexyloctane
Thanks to the innovative substance perfluorohexyloctane EvoTears® is lipophilic and yet has the same refractive index as the tear. This means that vision is not impaired. Perfluorohexyloctane has further advantageous properties previously unknown in dry eye therapy. EvoTears® spreads very quickly and rapidly forms a protective layer over the tear. This counteracts premature evaporation. In addition, one drop has a volume of approx. 10 µl only and therefore up to 280 drops per
3 ml content can be taken from a bottle of EvoTears®.
2. Being water-free
EvoTears® are the first water-free drops in the treatment of dry eyes as it only contains the substance perfluorohexyloctane. Thus, EvoTears® does not require any excipients such as preservatives, phosphates or emulsifiers.
EvoTears® represents the first anhydrous eye drops in the treatment of dry eyes. The effective protection against evaporation leads to patient satisfaction.
1 Tong L et al. Invest Ophthalmol Yis Sci, 2010. 51: 3449-3454
2 due to perfluorohexyloctane and being water-free
3 e.g. PC, smartphone, tablet